When you learn you have lung cancer, you’ll probably have many questions. Talking about treatment options with your doctors can help you feel confident when making decisions about your care ...

Learning that you have cancer can be an overwhelming experience. As you begin researching what steps to take after receiving a cancer diagnosis, you’ll probably hear a lot about getting a second ...

When you learn you have lung cancer, you’ll probably have many questions. Talking about treatment options with your doctor can help you feel better prepared to make decisions about your care ...

Thetis cells, a class of immune cells first described by MSK researchers in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.

Experts in nutrition and cancer at MSK explain what a high-fiber diet looks like — and why it may lower your risk of developing certain cancers.

An experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine autogene cevumeran continues to show potential to stimulate an immune response ...

Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN) and Memorial Sloan Kettering Cancer Center (MSK), a leading global cancer center, today announced a collaboration harnessing the ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient’s own immune T cells and engineering them to recognize specific targets ...

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood ...

Today researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from the first ever clinical trial to show that a high fiber plant based dietary intervention may delay progression ...

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups.

Lung cancer is the second-most common cancer and remains the leading cause of cancer death in the United States. But a variety of new treatments, many of them developed or tested at Memorial Sloan ...